Plutonium Biokinetics in Human Body A. Luciani - Kit-Bibliothek - FZK
Plutonium Biokinetics in Human Body A. Luciani - Kit-Bibliothek - FZK
Plutonium Biokinetics in Human Body A. Luciani - Kit-Bibliothek - FZK
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
As an example a practical application of the previous sensitivity analysis is shown <strong>in</strong><br />
the follow<strong>in</strong>g. The results of the sensitivity analysis for the respiratory tract allow to evaluate<br />
the effects of the modify<strong>in</strong>g factors proposed by ICRP for the parameters describ<strong>in</strong>g the<br />
particle transport <strong>in</strong> the human respiratory tract. In the Annexe E of Publication 66 of ICRP<br />
[57] modify<strong>in</strong>g factors Φ m are recommended by which the parameters of the respiratory<br />
model should be multiplied <strong>in</strong> order to consider alterations <strong>in</strong> the particle transport model due<br />
to factors such as age, smok<strong>in</strong>g, pollutants, disease or pharmacological agents. The respiratory<br />
model parameters that are supposed to be altered are the clearance from the BB1 bronchial<br />
compartment and the bb1 bronchiolar compartment, for almost all the causes of clearance<br />
alteration, and the clearance from the two alveolar-<strong>in</strong>terstitial compartments AI2 and AI3<br />
together with the fraction deposited <strong>in</strong> AI1, for the effects of cigarette smok<strong>in</strong>g. As suggested<br />
by the sensitivity analysis, only the cigarette smok<strong>in</strong>g, affect<strong>in</strong>g the clearance from the<br />
alveolar-<strong>in</strong>terstitial compartments, would significantly alter the ur<strong>in</strong>ary excretion of<br />
<strong>Plutonium</strong>. Assum<strong>in</strong>g the modify<strong>in</strong>g factors proposed by ICRP and us<strong>in</strong>g the Model-b for<br />
<strong>Plutonium</strong>, it was calculated that smok<strong>in</strong>g would cause an enhancement of the ur<strong>in</strong>ary<br />
excretion of type S <strong>Plutonium</strong> by 17 %, 43 % and 44 % at 100, 1,000 and 10,000 days post<br />
<strong>in</strong>halation, respectively (see Figure 3.1.27).<br />
Daily ur<strong>in</strong>ary excretion [d -1 ]<br />
1E-06<br />
1E-07<br />
Figure 3.1.27 Daily percentage ur<strong>in</strong>ary excretion of type S <strong>Plutonium</strong> for a smoker compared<br />
to a normal subject us<strong>in</strong>g the Model-b and the ICRP 66 respiratory tract model.<br />
3.1.5.4 Uncerta<strong>in</strong>ty analysis<br />
Normal Subject Smoker<br />
1 10 100 1000 10000 100000<br />
Days post <strong>in</strong>take [d]<br />
Uncerta<strong>in</strong>ty analyses of models are generally performed <strong>in</strong> order to determ<strong>in</strong>e the<br />
uncerta<strong>in</strong>ty of a model’s predictions that results from imprecisely known <strong>in</strong>put variables. In<br />
the specific context of the present work, the effects of <strong>in</strong>complete knowledge [167] of the<br />
128